Suil Pharma Ltd

Suil Pharma restores sight lost due to retinal diseases like macular degeneration and diabetic macular oedema. Our solution is an intravitreal injection, so no disruption to the existing treatment pathway, and offers a completely unique mechanism to treat the disease so it is effective in patients where the existing therapies are not. Our therapy is delivered as an adjunct to existing therapies and requires two injections per year, compared to between 8-12 injections with current therapies.